Results 131 to 140 of about 3,769 (208)

Targeted delivery of glucocerebrosidase to lysosomes: The LYSOTAC (LYSOsome-TArgeting Chimera) technology. [PDF]

open access: yesAsian J Pharm Sci
Kim HY   +11 more
europepmc   +1 more source

Exploring the long-term use of ambroxol in Gaucher disease type 2: insights from two pediatric cases. [PDF]

open access: yesFront Neurol
Aries C   +7 more
europepmc   +1 more source

Ambroxol mitigates cyclophosphamide-induced liver injury by suppressing TLR-4/NF-κB signaling and oxidative stress and upregulating cytoglobin, TXNRD1 and HMGB1. [PDF]

open access: yesWorld J Gastroenterol
Alruhaimi RS   +6 more
europepmc   +1 more source

Ambroxol, the cough expectorant with neuroprotective effects

open access: yesNeural Regeneration Research
Kristin Patzwaldt   +1 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy